AU2002215333A1 - Compositions for release of radiosensitizers, and methods of making and using the same - Google Patents
Compositions for release of radiosensitizers, and methods of making and using the sameInfo
- Publication number
- AU2002215333A1 AU2002215333A1 AU2002215333A AU1533302A AU2002215333A1 AU 2002215333 A1 AU2002215333 A1 AU 2002215333A1 AU 2002215333 A AU2002215333 A AU 2002215333A AU 1533302 A AU1533302 A AU 1533302A AU 2002215333 A1 AU2002215333 A1 AU 2002215333A1
- Authority
- AU
- Australia
- Prior art keywords
- radiosensitizers
- compositions
- release
- making
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/605—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the macromolecule containing phosphorus in the main chain, e.g. poly-phosphazene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23980700P | 2000-10-12 | 2000-10-12 | |
US60/239,807 | 2000-10-12 | ||
PCT/US2001/031817 WO2002030472A2 (en) | 2000-10-12 | 2001-10-12 | Compositions for release of radiosensitizers, and methods of making and using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002215333A1 true AU2002215333A1 (en) | 2002-04-22 |
Family
ID=22903824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002215333A Abandoned AU2002215333A1 (en) | 2000-10-12 | 2001-10-12 | Compositions for release of radiosensitizers, and methods of making and using the same |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020198135A1 (en) |
AU (1) | AU2002215333A1 (en) |
WO (1) | WO2002030472A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6537585B1 (en) * | 1999-03-26 | 2003-03-25 | Guilford Pharmaceuticals, Inc. | Methods and compositions for treating solid tumors |
WO2002005800A2 (en) * | 2000-07-17 | 2002-01-24 | Guilford Pharmaceuticals, Inc. | Compositions for sustained release of analgesic agents, and methods of making and using the same |
US6746661B2 (en) | 2000-11-16 | 2004-06-08 | Microspherix Llc | Brachytherapy seed |
WO2002068000A2 (en) * | 2000-11-16 | 2002-09-06 | Microspherix Llc | Polymeric imagable brachytherapy seed |
EP1545705A4 (en) | 2000-11-16 | 2010-04-28 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
WO2003060799A2 (en) * | 2002-01-09 | 2003-07-24 | Guilford Pharmaceuticals, Inc. | Compositions for treatment of central nervous system neoplasms, and methods of making and using the same |
KR100571823B1 (en) * | 2003-11-18 | 2006-04-17 | 삼성전자주식회사 | Apparatus for controlling blood circulation using magnetic field and method for the same |
EP1838305A1 (en) * | 2005-01-21 | 2007-10-03 | Richard H. Matthews | Radiosensitizer formulations comprising nitrohistidine derivatives |
US20070009089A1 (en) * | 2005-07-06 | 2007-01-11 | Vanderbilt University | Methods and apparatuses for making x-rays using electron-beam ion trap (EBIT) technology |
US20090169628A1 (en) | 2006-10-17 | 2009-07-02 | Armark Authentication Technologies, Llc | Article and method for focused delivery of therapeutic and/or diagnostic materials |
WO2009088777A1 (en) * | 2007-12-31 | 2009-07-16 | Armark Authentication Technologies, Llc | Article and method for focused delivery of therapeutic and/or diagnostic materials |
EP2542307A4 (en) | 2010-03-01 | 2013-10-09 | Intraop Medical Corp | Radiotherapy combined with hypoxic cell sensitizers |
EP2566522A4 (en) * | 2010-05-03 | 2015-10-28 | Univ Health Network | Imageable activatable agent for radiation therapy and method and system for radiation therapy |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010006026A (en) * | 1997-04-03 | 2001-01-15 | 존스 홉킨스 유니버시티 스쿨 오브 메디슨 | Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same |
EP0980269A1 (en) * | 1997-04-30 | 2000-02-23 | Guilford Pharmaceuticals Inc. | Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same |
US6153212A (en) * | 1998-10-02 | 2000-11-28 | Guilford Pharmaceuticals Inc. | Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same |
US6419709B1 (en) * | 1998-10-02 | 2002-07-16 | Guilford Pharmaceuticals, Inc. | Biodegradable terephthalate polyester-poly(Phosphite) compositions, articles, and methods of using the same |
US6350464B1 (en) * | 1999-01-11 | 2002-02-26 | Guilford Pharmaceuticals, Inc. | Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
US6537585B1 (en) * | 1999-03-26 | 2003-03-25 | Guilford Pharmaceuticals, Inc. | Methods and compositions for treating solid tumors |
WO2002004544A2 (en) * | 2000-07-06 | 2002-01-17 | Guilford Pharmaceuticals | Polymers and polymerization processes |
WO2002005800A2 (en) * | 2000-07-17 | 2002-01-24 | Guilford Pharmaceuticals, Inc. | Compositions for sustained release of analgesic agents, and methods of making and using the same |
US20020141966A1 (en) * | 2000-11-16 | 2002-10-03 | Wenbin Dang | Compositions for treatment of malignant effusions, and methods of making and using the same |
-
2001
- 2001-10-12 US US09/976,283 patent/US20020198135A1/en not_active Abandoned
- 2001-10-12 AU AU2002215333A patent/AU2002215333A1/en not_active Abandoned
- 2001-10-12 WO PCT/US2001/031817 patent/WO2002030472A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002030472A2 (en) | 2002-04-18 |
US20020198135A1 (en) | 2002-12-26 |
WO2002030472A3 (en) | 2002-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001280597A1 (en) | Compositions for sustained release of analgesic agents, and methods of making and using the same | |
AU2002213273A1 (en) | Stenoprophiluric matrices, and methods of making and using the same | |
AU2001290825A1 (en) | Controlled release formulations and methods for their production and use | |
AU2001276048A1 (en) | Rapid-melt semi-solid compositions, methods of making same and methods of using same | |
AU2001279284A1 (en) | Rapid-melt semi-solid compositions, methods of making same and methods of using same | |
AU2001280604A1 (en) | Compositions comprising icariside i and anhydroicaritin and methods for making the same | |
AU2002357119A1 (en) | Mitocidal compositions and methods | |
AU2001240115A1 (en) | Method for the preparation of tetrahydrobenzothiepines | |
AU2002217226A1 (en) | Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate | |
GB9903216D0 (en) | Preservative compounds,compositions and methods of making and using the same | |
AU2001286701A1 (en) | Hyaluronan-based antiadhesion compositions, their preparation and use | |
AU2002225894A1 (en) | Methods and compositions for the control of coccidiosis | |
AU2002215333A1 (en) | Compositions for release of radiosensitizers, and methods of making and using the same | |
AU2002357748A1 (en) | Osteopontin-related compositions and methods | |
AU2002356405A1 (en) | Locking amplifier | |
AU2001270310A1 (en) | Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same | |
AU3883800A (en) | Hob-bp2h compositions, methods and uses thereof | |
AU5179800A (en) | Mycolactone and related compounds, compositions and methods of use | |
AU2001275201A1 (en) | Acne-treating composition | |
AU2001287852A1 (en) | Composition | |
AU2001232089A1 (en) | Compound, composition and use | |
AU2002365136A1 (en) | Compositions and methods for controlled release | |
AU2001232080A1 (en) | Compound, compositions and use | |
AU2001287732A1 (en) | Copolycarbonate-based composition | |
AU2001262163A1 (en) | Composition |